As of 2026-10-07, the Relative Valuation of Selecta Biosciences Inc (SELB) is (2.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -338.1%.
The range of the Relative Valuation is (4.09) - 0.75 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 24.9x | 21.4x |
| Forward P/E multiples | 25.0x - 29.6x | 27.3x |
| Fair Price | (4.09) - 0.75 | (2.10) |
| Upside | -564.0% - -14.9% | -338.1% |
| Date | P/E |